Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shandong University
• Collaborators: Linyi People's Hospital; Qingdao Eastsea Pharmaceutical Co., Ltd.; Taian City Central Hospital

Criteria

Inclusion Criteria:

• the presence of Rome III criteria for IBS ;

• Aged between 18 and 65 years old

Exclusion Criteria:

• Antibiotic, probiotic or laxative usage within 4 weeks.

• organic gastrointestinal diseases

• Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction, thyroid disease or tumor etc.

• pregnancy or lactation.

• previous major or complicated abdominal surgery.

• severe endometriosis and dementia